Valuation AstraZeneca PLC BOERSE MUENCHEN

Stocks

Real-time BOERSE MUENCHEN Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-1.26%

06-26	European Equities Lower in Friday Trading; Unilever Weighs Offer for Thorne Valued at Up to $4 Billion	MT
06-26	Daiichi Sankyo and AstraZeneca Announce Datroway Recommends for Approval in EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	293,493	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	1.97%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	312,738	305,498	297,494
Change	-	12.57%	-0.25%	-1.74%	36.64%	0.5%	-2.32%	-2.62%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	23.7x	20.7x	17.8x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	5.52x	4.76x	3.88x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.4x	1.1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.63x	4.37x	4.1x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.94x	4.55x	4.16x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	14x	12.5x	11.1x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	14.7x	13x	11.5x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	30x	22.2x	19.5x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.34%	4.5%	5.12%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.337	3.524	3.659
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.76%	1.86%	1.93%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.979	9.145	10.61
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	41.8%	38.5%	34.5%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,321	67,157	71,556
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,337	24,470	26,751
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,241	23,587	25,911
Net income ¹	112	3,288	5,961	7,035	10,225	12,488	14,137	16,137
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,245	12,005	4,001
Reference price ²	117.51	135.16	135.02	131.05	185.60	189.23	189.23	189.23
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,550,996	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	35.2x	12.84x	26.1x	0.57%	1,077B
JOHNSON & JOHNSON	27.22x	6.26x	17.02x	2.1%	613B
ABBVIE INC.	32.17x	7.47x	15.29x	2.73%	448B
ROCHE HOLDING AG	17.9x	4.45x	10.94x	2.98%	332B
NOVARTIS AG	21.69x	5.59x	13.51x	2.83%	286B
NOVO NORDISK A/S	14.19x	5.21x	10.72x	3.54%	215B
AMGEN INC.	23.3x	6.21x	10.84x	2.81%	193B
GILEAD SCIENCES, INC.	-45.82x	5.53x	30.47x	2.54%	159B
PFIZER INC.	11.36x	3.03x	7.37x	7.21%	138B
Average	15.25x	6.29x	15.81x	3.03%	384.56B
Weighted average by Cap.	23.98x	8.00x	18.25x	2.2%